In this video, Dr. Brian G.M. Durie shares different treatment options that may be available to a myeloma patient for whom CyBorD has not been effective. 

BOTTOM LINE:
Discuss treatment with your doctor and match accordingly to the pattern of your myeloma history.

Have a question? Submit it to [email protected]

IMF Chairman Brian G.M. Durie, MD welcomes your questions about the latest myeloma treatments, research, controversies and quality of life issues. If you have a question you think might be of interest to the myeloma community, please send to [email protected]!

For questions of a specific personal nature, please call the IMF InfoLine coordinators at 800.452.2873 or email them at [email protected]


Image of Dr. Brian G.M. DurieDr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.

Previous Post
The good and the good for 2017: how results of the SWOG 0777 trial and serum Freelite testing can help myeloma patients
Next Post
Can MGUS be linked to kidney problems?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.